Search database
LIST OPTIONS
Filter
102
Filtered Results: 102
Text search: heterologous
Featured
Language
Document type
Guidelines
40
No document type
32
Studies & Reports
13
Manuals
5
Fact sheets
5
Strategic & Response Plan
4
Situation Updates
2
Infographics
1
Countries / Regions
Brazil
8
India
6
Argentina
5
Africa
3
Latin America and the Carribbean
3
South Africa
3
Nigeria
2
Mozambique
2
Paraguay
2
Bolivia
2
Russia
2
Chile
1
Philippines
1
Global
1
Asia
1
Tanzania
1
Germany
1
East and Southern Africa
1
Uganda
1
Indonesia
1
Ecuador
1
Authors & Publishers
World Health Organization WHO
35
Ministerio de Salud Argentina
4
OPAS
4
World Health Organization
4
Abela-Ridder, B.
2
Dirección de Control de Enfermedades Inmunoprevenibles
2
Federal Ministry of Health, Nigeria
2
Feraud, H.
2
Indian Council of Medical Research
2
Organisation Mondiale de la Santé OMS
2
Organización Mundial de la Salud OMS
2
Organización Mundial de Saude and OPAS
2
Organização Mundial da Saúde (OMS)
2
Rupprecht, C.
2
WHO
2
World Health Organisation (WHO)
2
World Health Organization (WHO)
2
World Heart Federation
2
Abubakar, B.K.
1
Africa CDC Centres for Disease Control and Prevention
1
African Union
1
Ahmad, U., Chau, D.M. et al.
1
Bill & Melinda Gates Foundation
1
BioMed Central
1
BMC Part of Springer Nature
1
BooMed Central
1
Dept. of Health South Africa
1
Dra. María Cristina San Miguel de Vera
1
E. Malchiodi, J.P. Ioset, et al.
1
Elsevier Ltd.
1
Erwinanto, A. Santoso, J. N. E. Putranto, et al.,
1
Fairlamb, A.H.
1
Ference, B.A.
1
Fooks, A,
1
Fooks, A.
1
Garratt, A.
1
Gavi, the Vaccine Alliance
1
Gerald Keusch, Keith McAdam, Patricia Cuff, Michelle Mancher, and Emily R. Busta
1
Guo, J.
1
HelpAge
1
Hill, A.
1
Hindawi Publishing Corporation
1
Horn, D.
1
IACAPAP
1
Ibarra-Cerdena, C.
1
Indonesian Heart Association
1
Izeta-Alberdi, A.
1
J. A. Triccas, C. Counoupas
1
J. J. C. Nuttal, B. S. Eley
1
Jara A., Undurraga E. A. et al
1
JCI insight
1
Journal of Cystic Fibrosis
1
Journal of Movements Disorders
1
Logunov, D.Y, et al.
1
M. A. Gasper, A. C. Hesseling, I. Mohar, et al.
1
Ministerio da Saude Brasilia
1
Ministerio de Salud
1
Ministerio de Salud Bolivia
1
Ministerio de Salud Pública de Ecuador
1
Ministerio de Salud Pública, Paraguay
1
Ministerio de Salud, Argentina
1
Ministério da Saúde, Brasil
1
Ministry of Health & Family Welfare India
1
Moo-llanes, D.
1
Muntean Al., Popa M.
1
National Academies of Sciences, Engineering, and Medicine
1
National Centre for Disease Control
1
National Department of Health, South Africa
1
National Health Mission (NHM), Ministry of Health & Family Welfare, Government of India
1
National Institue of communicable Diseases, India
1
National Rabies Programme
1
O. Bandmann
1
OPAS, OMS
1
OPS
1
Organización Panamericana de la Salud
1
Pan American Health Organisation PAHO
1
Pan American Health Organization PAHO
1
Pinazo, M.J.
1
Pneumonia
1
Popa G.
1
R. R. Althoff
1
R. Walker
1
Ramsey,J.
1
Ray, K.K.
1
RCC Service
1
Saudi Journal of Biological Sciences
1
Secretaria Extraordinária de Enfrentamento à COVID-19, Brasil
1
Séverin, T. et al.
1
TDR
1
Trials
1
U. Williams
1
UNICEF
1
V. Nankabirwa , J. K. Tumwine, O. Namugga, et al.
1
Vygen-Bonnet S, Koch J, Bogdan C, et al.
1
World Health Organization WHO, Regional Office of Africa
1
World Health Organization WHO, SAGE
1
World Health Organization, Regional Office for the Americas
1
Publication Years
Category
Countries
34
Clinical Guidelines
11
Public Health
4
Pharmacy & Technologies
3
Capacity Building
1
Women & Child Health
1
Toolboxes
COVID-19
48
NTDs
8
Rapid Response
5
TB
4
NCDs
3
Mental Health
2
Zika
2
Ebola & Marburg
1
Planetary Health
1
Pharmacy
1
Health Financing Toolbox
1
Polio
1
Global Health Education
1
Временное руководство, Первый выпуск 8 января 2021 г., Обновлено 15 июня 2021 г., Обновлено 19 ноября 2021 г.
Rabies has an enormous impact on both agriculture and conservation biology, but its greatest burden is undeniably on public health. As such, routine methods for rapid risk assessment after human exposures to rabies as well as applications for laboratory-based surveillance, production of biologicals ... more
Declarations of interests were collected from all external contributors and assessed for any conflicts of interest. Summaries of the reported interests can be found on the SAGE meeting website and SAGE Covid-19 Working Group webpage. This guidance should be considered along with the broader COVID-... more
Organización Mundial de la Salud. (‎2022)‎. Recomendaciones provisionales sobre el uso de la vacuna CanSinoBIO Ad5-nCoV-S [‎recombinante]‎ (‎Convidecia™)‎ contra la COVID-19: orientaciones provisionales, primera publicación: 19 de mayo de 2022.
The Lancet Volume 5, Issue 10100972October 2024 Chagas Disease Serie 3
Weekly epidemiological recordRelevé épidémiologique hebdomadaire 3 MAY 2024, 99th YEAR / 3 MAI 2024, 99e ANNÉE No 18, 2024, 99, 203–224 The WHO position papers are concerned primarily with the use of vaccines in large-scale vaccination programmes. The position papers are intended for use by... more
orientations provisoires, première publication: 10 février 2021, mise à jour : 21 avril 2021, dernière mise à jour : 30 juillet 2021
временное руководство. Первый выпуск: 10 февраля 2021 г. Обновлено: 21 апреля 2021 г. Последнее обновление 30 июля 2021г.
These WHO interim recommendations for use of the COVID-19 vaccine BIBP produced by Sinopharm were developed on the basis of advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE) and the evidence summary included in the background document and annexes referenced below. Th... more
Interim recommendations for the use of ChAdOx1-S [recombinant] COVID-19 vaccine (AstraZeneca COVID-19 AZD1222 Vaxzevria™, SII COVISHIELD™ vaccine) - Last updated 30 July 2021
Data for Action March 2022, Issue 5
Review Triccas and Counoupas Pneumonia (2016) 8:18; DOI 10.1186/s41479-016-0020-z
Esta orientação provisória foi desenvolvida com base na recomendação emitida pelo Grupo Consultivo Estratégico de Especialistas (SAGE) em imunização, em sua reunião extraordinária de 5 de janeiro de 2021, e atualizada durante sua reunião extraordinária de 27 de maio de 2021 (2), sendo no... more
orientaciones provisionales, primera publicación: 24 de mayo de 2021, actualización: 21 de octubre de 2021, actualización: 15 de marzo de 2022
These WHO interim recommendations on the use of the Pfizer – BioNTech BNT162b2 vaccine against Covid-19 were developed on the basis of advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE) and the evidence summary included in the background document referenced below. fir... more
27 September 2022 These WHO interim recommendations for use of the Novavax NVX-CoV2373 vaccine were developed on the basis of advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE) and the evidence summary included in the background document and annexes referenced below.